Concepedia

Per‐Ola Önnervik

PÖ

Statistics

Publications

5

Citations

331

H-Index

5

Active since

1991

Affiliations

AstraZeneca (Sweden)(Current)

Lund University

Per‐Ola Önnervik is an author at AstraZeneca (Sweden) specializing in cell biology, glycosaminoglycans, and pulmonary inflammation.

Publications per year

1991–2009

5

Publications

5

Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile

Gordon J. Gaschler, Marko Škrtić, Caleb C. J. Zavitz et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 110 citations

, , +17

Proliferation of cultured fibroblasts is inhibited by<scp>L</scp>‐Iduronate—containing glycosaminoglycans

Gunilla Westergren‐Thorsson, Per‐Ola Önnervik, Lars-Åke Fransson et al. · Journal of Cellular Physiology · 1991 · 103 citations

, , +13

Measurement of MR signal and T2* in lung to characterize a tight skin mouse model of emphysema using single‐point imaging

Lars Olsson, Maria Lindahl, Per‐Ola Önnervik et al. · Journal of Magnetic Resonance Imaging · 2007 · 54 citations

, , +13

L-Iduronate-Rich Glycosaminoglycans Inhibit Growth of Normal Fibroblasts Independently of Serum or Added Growth Factors

Gunilla Westergren‐Thorsson, Susanne Persson, Anders Isaksson et al. · Experimental Cell Research · 1993 · 42 citations

, , +9

<sup>1</sup>H and hyperpolarized <sup>3</sup>He MR imaging of mouse with LPS‐induced inflammation

Lars Olsson, Amir Smailagic, Per‐Ola Önnervik et al. · Journal of Magnetic Resonance Imaging · 2009 · 22 citations

, , +17

1–5 of 5